Markets
Leaderboard
Will the antibody developed by Israeli scientists be safe and effective against Covid-19 in human testing by the end of 2020? Yes: real money —, play money 61% No: real money —, play money 39% Volume: real money 48.308015, play money 2226.62191201 Bettors: real money 0, play money 8 Categories: Science, Transmissible Diseases, Covid-19 (Coronavirus), Immunity Studies Related markets Antarctic sea ice minimum to decrease in 2027? (ID: 235045) Volume: real 500.10026694, play 50000 Bettors: real 4, play 0 Leading (real money): Antarctic sea ice minimum to decrease in 2027? 81% Leading (play money): Antarctic sea ice minimum to decrease in 2027? 81% Nipah virus declared a public health emergency by the WHO in 2026? (ID: 233776) Volume: real 100.18015496, play 14933.4347 Bettors: real 4, play 3 Leading (real money): Nipah virus declared a public health emergency by the WHO in 2026? 11% Leading (play money): Nipah virus declared a public health emergency by the WHO in 2026? 6%

Will the antibody developed by Israeli scientists be safe and effective against Covid-19 in human testing by the end of 2020?

Market Rules

Scientists at the Israel Institute of Biological Research announced in April of 2020 the development of an antibody to SARS-COV-2, which capable of neutralizing the virus in cells.

Although several laboratories worldwide are making progress in search of a safe and effective antibody, Israeli scientists have declared that they are the first to achieve three parameters that can determine the success of the antibody in humans:

    it has no harmful proteins that would make it difficult to use;
    the antibody is able to neutralize the coronavirus; and
    it neutralizes the most aggressive strain of the known coronavirus.

The next steps include in the research will be the testing on animals, and, if successful at this stage, the antibody will be tested on humans.

If the antibody developed in Israel is proven to be safe and effective in humans by December 31st, 2020, this market will be resolved as "Yes".

Related Markets